Treatment of repeated unexplained in vitro fertilization failure with intravenous immunoglobulin: A randomized, placebo-controlled Canadian trial

Fertility and Sterility

Volumn 74, Issue 6, 2000, Pages 1108-1113

  Stephenson, Mary D ^a   Fluker, Margo R ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b Genesis Fertility Centre   (Canada)

Author keywords

In vitro fertilization; Infertility; Intravenous immunoglobulin

Indexed keywords

ANTINUCLEAR ANTIBODY; ESTRADIOL; IMMUNOGLOBULIN; PHOSPHOLIPID ANTIBODY; PLACEBO; PROGESTERONE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EMBRYO TRANSFER; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; MAJOR CLINICAL STUDY; PREGNANCY COMPLICATION; PREGNANCY RATE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ULTRASOUND;

ADULT; BIRTH RATE; DOUBLE-BLIND METHOD; FEMALE; FERTILIZATION IN VITRO; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFERTILITY, FEMALE; PLACEBOS; PROSPECTIVE STUDIES; RETREATMENT; TREATMENT FAILURE;

EID: 0033635452     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(00)01622-8     Document Type: Article

References (40)

1. Assisted reproductive technology in the United States; 1996 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry
2. Reducing the risk of multiple births by transfer of two embryos after in vitro fertilization
3. The effect of embryo quality on subsequent pregnancy rates after in vitro fertilization
4. Prediction of implantation by the sonographic appearance of the endometrium during controlled ovarian stimulation for in vitro fertilization (IVF)
5. The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells; is HLA-G the public ligand for natural killer cell inhibitory receptors?
6. Bidirectional cytokine interactions in the maternal-fetal relationship; is successful pregnancy a TH2 phenomenon?
7. T-helper 1-type immunity to trophoblast in women with recurrent spontaneous abortion
8. Intravenous immunoglobulin (IVIG) in the prevention of implantion failures
9. Intravenous immunoglobulin preceding in vitro fertilization-embryo transfer for patients with repeated failure of embryo transfer
10. Immunological treatment of implantation failure
11. Intravenous immunoglobulin for in-vitro fertilization failure
12. The use of combined heparin/aspirin and immunoglobulin G therapy in the treatment of in vitro fertilization patients with antithyroid antibodies
13. A rational basis for the use of combined heparin/aspirin and IVIG immunotherapy in the treatment of recurrent IVF failure associated with antiphospholipid antibodies
14. The selective use of heparin/aspirin therapy, alone or in combination with intravenous immunoglobulin G, in the management of antiphospholipid antibody-positive women undergoing in vitro fertilization
15. Avoidance of triplet pregnancies by elective transfer of two good quality embryos
16. The use of the dilute Russell viper venom time for the diagnosis of lupus anticoagulant
17. Laboratory diagnosis of lupus inhibitors; a comparison of the tissue thromboplastin inhibition procedure with a new platelet neutralization procedure
18. Evaluation of the anticardiolipin antibody test; report of an international workshop held 4 April 1986
19. New treatments, preliminary results, and clinical practice
20. Hydrosalpinx and IVF outcome; a prospective, randomized multicentre trial in Scandinavia on salpingectomy prior to IVF
21. Mechanism of intravenous immune globulin therapy in antibody mediated autoimmune diseases
22. Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gammaglobulin
23. Suppression of immunoglobulin production of lymphocytes by intravenous immunoglobulin
24. Normal immunoglobulin G (IgG) for therapeutic use (intravenous Ig) contains antiidiotypic specificities against an immunodominant, disease-associated, cross-reactive idiotype of human anti-thyroglobulin autoantibodies
25. Down-regulation of cytokine production and IL-2 receptor expression by pooled human IgG
26. Polyvalent immunoglobulin for intravenous use interferes with cell proliferation in vitro
27. Immunomodulatory and anti-microbial efficacy of intravenous immunoglobulin in bone marrow transplantation
28. High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments
29. The use and mechanisms of action of intravenous immunoglobulin; an update
30. Intravenous immunoglobulin inhibits natural killer cell activity in vivo in women with recurrent spontaneous abortion
31. Elevated peripheral blood natural killer cells are effectively downregulated by immunoglobulin G infusion in women with recurrent spontaneous abortions
32. Parental human leukocyte antigens and implantation failure after in vitro fertilization
33. Reproductive failure due to spontaneous abortion and recurrent miscarriage
34. Lupus anticoagulant and recurrent fetal loss; successful treatment with gammaglobulin
35. Recurrent first trimester spontaneous abortion associated with antiphospholipid antibodies; a pilot study of treatment with intravenous immunoglobulin
36. Pregnancy complicated by the antiphospholipid syndrome; outcomes with intravenous immunoglobulin therapy
37. Intravenous immunoglobulin therapy for recurrent spontaneous abortion; a meta-analysis